Phase 3
Completed N=250
Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)
Ventral Hernia Repair
Source: ClinicalTrials.gov NCT03945357 ↗
Enrolled (actual)
250
Serious AEs
5.6%
Results posted
Aug 2023
Primary outcomePrimary: Surgical Site Infection — 11; 10 Participants
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
This is a study to determine if the incidence of infection at the Surgical SitE is impacted if with Antibiotic Irrigation is used during Ventral Hernia Repair (RINSE Trial)
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Surgical Site Infection |
11; 10 | — |
| SECONDARY Incidence of SSI Requiring Intervention |
8; 8 | — |
Eligibility Criteria
Inclusion Criteria
- Age >18 y/o.
- Elective, open ventral hernia repair in a retromuscular fashion, with or without TAR.
- Clean, clean-contaminated, or contaminated wounds.
Exclusion Criteria
- Age <18 y/o.
- Pregnancy.
- Emergency hernia repair.
- Laparoscopic, robotic, or hybrid approach.
- Dirty wounds.
- Use of biologic or absorbable synthetic mesh.
- Onlay, intraperitoneal or preperitoneal mesh placement.
Data sourced from ClinicalTrials.gov (NCT03945357). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.